Literature DB >> 21593251

Tgf-beta-mediated FasL-Fas-Caspase pathway is crucial during palatogenesis.

X Huang1, T Yokota, J Iwata, Y Chai.   

Abstract

Programmed cell death, or apoptosis, is one of the fates of the medial edge epithelium (MEE) during palatal fusion. Transforming growth factor β (Tgf-β) signaling (such as Tgf-β3) is required for the disappearance of the MEE, but the relationship between Tgf-β3 and apoptosis remains unclear. Here we show that the Fas ligand (FasL)-Fas-Caspase extrinsic apoptosis pathway functions during palatal fusion in wild-type mice, but is not detectable in mice lacking Tgf-β3 (Tgf-β3 (-/-) ) or Tgfβr2 in the MEE (K14-Cre;Tgfbr2 (fl/fl)). Inhibition of the FasL-Fas system results in persistence of the midline epithelial seam (MES) and inhibition of caspase activity during palatal organ culture. Moreover, ectopic FasL protein induces apoptosis in MES of K14-Cre;Tgfbr2 (fl/fl) mice. Thus, we conclude that the FasL-Fas-caspase extrinsic apoptosis pathway is regulated by the Tgf-β3 signaling cascade and is essential for palatal fusion during craniofacial development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593251      PMCID: PMC3170164          DOI: 10.1177/0022034511408613

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  31 in total

1.  Fate-mapping of the epithelial seam during palatal fusion rules out epithelial-mesenchymal transformation.

Authors:  Forugh Vaziri Sani; Kristina Hallberg; Brian D Harfe; Andrew P McMahon; Anders Linde; Amel Gritli-Linde
Journal:  Dev Biol       Date:  2005-09-15       Impact factor: 3.582

2.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 3.  Apoptotic pathways: the roads to ruin.

Authors:  D R Green
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

Review 4.  Programmed cell death and cell transformation in craniofacial development.

Authors:  C F Shuler
Journal:  Crit Rev Oral Biol Med       Date:  1995

Review 5.  Recent advances in craniofacial morphogenesis.

Authors:  Yang Chai; Robert E Maxson
Journal:  Dev Dyn       Date:  2006-09       Impact factor: 3.780

6.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

Authors:  J Dhein; H Walczak; C Bäumler; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

7.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

8.  Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.

Authors:  V Kaartinen; J W Voncken; C Shuler; D Warburton; D Bu; N Heisterkamp; J Groffen
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

9.  Transforming growth factor-beta 3 is required for secondary palate fusion.

Authors:  G Proetzel; S A Pawlowski; M V Wiles; M Yin; G P Boivin; P N Howles; J Ding; M W Ferguson; T Doetschman
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

10.  Pathogenesis of cleft palate in TGF-beta3 knockout mice.

Authors:  Y Taya; S O'Kane; M W Ferguson
Journal:  Development       Date:  1999-09       Impact factor: 6.868

View more
  11 in total

1.  Crispld2 is required for neural crest cell migration and cell viability during zebrafish craniofacial development.

Authors:  Eric C Swindell; Qiuping Yuan; Lorena E Maili; Bhavna Tandon; Daniel S Wagner; Jacqueline T Hecht
Journal:  Genesis       Date:  2015-09-05       Impact factor: 2.487

2.  Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis.

Authors:  Bill X Wu; Anqi Li; Liming Lei; Satoshi Kaneko; Caroline Wallace; Xue Li; Zihai Li
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.157

3.  Transcriptome profiling of CTLs regulated by rapamycin using RNA-Seq.

Authors:  Elliot Mattson; Lingyang Xu; Lei Li; George E Liu; Zhengguo Xiao
Journal:  Immunogenetics       Date:  2014-08-13       Impact factor: 2.846

4.  Chloroquine regulates the proliferation and apoptosis of palate development on mice embryo by activating P53 through blocking autophagy in vitro.

Authors:  Jing Chen; Yaxia Yao; Xiaotong Wang; Yijia Wang; Tianli Li; Juan Du
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-08-10       Impact factor: 2.723

5.  Multiple tissue-specific requirements for the BMP antagonist Noggin in development of the mammalian craniofacial skeleton.

Authors:  Maiko Matsui; John Klingensmith
Journal:  Dev Biol       Date:  2014-06-17       Impact factor: 3.582

6.  Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis.

Authors:  Rocca d'Amaro; Rolf Scheidegger; Susan Blumer; Pawel Pazera; Christos Katsaros; Daniel Graf; Matthias Chiquet
Journal:  Front Physiol       Date:  2012-09-24       Impact factor: 4.566

7.  Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.

Authors:  Zachary S Buchwald; Jennifer R Kiesel; Richard DiPaolo; Meghana S Pagadala; Rajeev Aurora
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

Review 8.  TGF-β Signaling and the Epithelial-Mesenchymal Transition during Palatal Fusion.

Authors:  Akira Nakajima; Charles F Shuler; Alexander O D Gulka; Jun-Ichi Hanai
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

9.  Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat.

Authors:  Shani Ben-Lulu; Yulia Pollak; Jorge Mogilner; Jacob Bejar; Arnold G Coran; Igor Sukhotnik
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  IRF6 is the mediator of TGFβ3 during regulation of the epithelial mesenchymal transition and palatal fusion.

Authors:  Chen-Yeh Ke; Wen-Lin Xiao; Chun-Ming Chen; Lun-Jou Lo; Fen-Hwa Wong
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.